Bayer AG Selects Interpublic Group as Global Agency Partner for Consumer Health Division
Reuters
Sep 30, 2025
Bayer AG Selects Interpublic Group as Global Agency Partner for Consumer Health Division
Bayer AG has selected Interpublic Group $(IPG)$ as its global media, production, and creative agency partner for the Consumer Health division. Under the new integrated agency approach, IPG will be responsible for marketing activities for several of Bayer's leading self-care brands, including Aspirin, Bepanthen, Claritin, and Canesten. The new agency model is designed to enhance Bayer's media buying power, deliver more personalized and responsive content to consumers, and ensure global consistency while maintaining local relevance. The transition to the new agency structure is expected to be completed by January 1, following a transition and handover period. The partnership also anticipates leveraging advancements in generative AI tools and capabilities to improve consumer engagement at the local level.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bayer AG published the original content used to generate this news brief via Business Wire (Ref. ID: 20250929587381) on September 29, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.